Safety alertSource: FDA Drug Enforcement Reports
Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only
Accord Healthcare, Inc. issued a Class II recall for Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), in 1000-count bottles, NDC 16729-448-17, manufactured by Intas Pharmaceuticals Limited. The recall reason cited is that the product is subpotent.
Most relevant for: Patients prescribed levothyroxine 50 mcg tablets from this manufacturing lot for thyroid hormone replacement.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026